Skip to main content

[vc_row][vc_column][vc_single_image image="54058" img_size="full" alignment="center"][vc_column_text] No-Shave November Is Back and Has Never Been Scruffier FOR IMMEDIATE RELEASE: October 6, 2022 at 12:00 PM [ROCKVILLE, MD, OCTOBER 6, 2022] — No-Shave November rallies 13 cancer-related nonprofit organizations, including the National Foundation for Cancer Research (NFCR), to get hairy for its...

[vc_row][vc_column][vc_single_image image="52583" img_size="full" alignment="center"][vc_column_text] Recognized for Identifying and Overcoming Barriers in the Tumor Microenvironment To Improve Delivery and Efficacy of Anti-Cancer Medicines [/vc_column_text][vc_column_text] ROCKVILLE, MD - The National Foundation for Cancer Research (NFCR) announced today that Rakesh K. Jain, Ph.D., has been selected to receive the 2022 Szent-Györgyi...

[vc_row][vc_column width="1/2"][vc_single_image image="45792" img_size="medium"][/vc_column][vc_column width="1/2"][vc_single_image image="45789" img_size="medium"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]FOR IMMEDIATE RELEASE: November 1, 2021 CONTACTS: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Engagement E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 No-Shave November (Matthew Hill Foundation, Inc.) Brett Hartigan, Communication Coordinator E-mail: brett.hartigan@no-shave.org ROCKVILLE, MD, & EMERYVILLE, CA – The National Foundation for Cancer Research...

FOR IMMEDIATE RELEASE: May 25, 2021 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 [caption id="attachment_43197" align="alignnone" width="1600"] Representatives of the top cancer-battling innovations of the Salisbury Award Competition[/caption] The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto...

[vc_row][vc_column][vc_column_text] BEVERLY, Mass., May 10, 2021 (GLOBE NEWSWIRE) — TellBio, Inc., a development stage biotechnology company focused on revolutionizing the detection and treatment of cancer through its unique and proprietary circulating tumor cell (CTC) technology, TellDx, and complementary therapeutics platform, TellRx, today announced the closing of...

[vc_row][vc_column][/vc_column][vc_column_text]FOR IMMEDIATE RELEASE: February 18, 2021 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Engagement & Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 [caption id="attachment_40872" align="aligncenter" width="1050"] 2021 Szent-Gyorgyi Prize Winners Tak Mak and Mark Davis[/caption] ROCKVILLE, MD - The National Foundation for Cancer Research (NFCR) announced...

FOR IMMEDIATE RELEASE: December 3, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of Commercialization and Patient Impact ROCKVILLE, MD – The National Foundation for...

[vc_row][vc_column][vc_column_text]FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng and Project Advances New Systems Biology Paradigm for Cancer Treatment World-First Phase...

FOR IMMEDIATE RELEASE: April 14, 2020                                                  CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD –The National Foundation for Cancer Research (NFCR) has launched an online resource center targeted especially to cancer patients and caregivers during the COVID-19...